Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF
The recruitment status of this study is unknown because the information has not been verified recently.
Verified July 2012 by Evangelismos Hospital.
Recruitment status was Recruiting
Information provided by (Responsible Party):
Nikos Viazis, Evangelismos Hospital
First received: May 22, 2012
Last updated: July 26, 2012
Last verified: July 2012
The aim of our study is to prospectively identify, at diagnosis, factors predictive of non-response or loss of response in patients with inflammatory bowel disease treated with anti-TNF.
Inflammatory Bowel Disease
||Observational Model: Case-Crossover
Time Perspective: Prospective
||Predictors of Non-response and Loss of Response in IBD Patients Treated With Anti-TNF.
Biospecimen Retention: Samples With DNA
Whole blood Serum Bowel mucosal tissue
| Estimated Enrollment:
| Study Start Date:
| Estimated Study Completion Date:
| Estimated Primary Completion Date:
||July 2012 (Final data collection date for primary outcome measure)
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
IBD patients treated with anti-TNF that need dose escalation.
- Active Crohn's luminal ileitis, colitis or ileocolitis necessitating therapy with anti-TNF, according to the physician's judgment, based on the current ECCO guidelines.
- Corticosteroid resistant or corticosteroid dependent ulcerative colitis, necessitating therapy with anti-TNF, according to the physician's judgment, based on the current ECCO guidelines.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01605188
|Athens, Greece |
|Contact: Nikos Viazis, Consultant 0036977617000 firstname.lastname@example.org |
|Contact: Theodoros Koukouratos, Senior email@example.com |
|Principal Investigator: Nikos Viazis |
|Sub-Investigator: Theodoros Koukouratos |
No publications provided
||Nikos Viazis, Consaltant Gastroenterologist, Evangelismos Hospital
History of Changes
|Other Study ID Numbers:
|Study First Received:
||May 22, 2012
||July 26, 2012
||Greece: Ethics Committee
Greece: Ministry of Health and Welfare
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on October 20, 2014
Inflammatory Bowel Diseases
Digestive System Diseases